Use of injectable depot medroxyprogesterone acetate in lactating Indian women
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A.
Lancet 344(8915): 134-135
1994
ISSN/ISBN: 0140-6736 PMID: 7912374 DOI: 10.1016/s0140-6736(94)91323-4Document Number: 287464
This letter questions the safety of injectable depot medroxyprogesterone acetate for use in lactating women in populations with a high prevalence of calcium deficiency, e.g. Indian women.
Document emailed within 0-6 h
Related Documents
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Jawalekar, K.S.; Chitale, M.V. 1973: Medroxyprogesterone acetate as an injectable contraceptive--its utility in Indian women Journal of Obstetrics and Gynaecology of India 23(1): 55-57
Cuong, D.T.; My Huong, N.T. 1996: Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in Vietnamese women Contraception 54(3): 169-179
Lali, P.; Chandra, L.; Gupta, R.P. 1996: Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: A preliminary study Contraception 53(6): 363-365
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Hu, E.; Ikeako, L.C.; Obiora-Okafor, N.C. 2012: The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 21(3): 266-271
Hu, E.; Ikeako, L.C.; Obiora-Okafor, N.C. 2012: The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 21(3): 266-271
Cursino, K.; Sider, M.; Pavin, E.J.ão.; dos Santos, P.d.N.é S.; Bahamondes, L.; Zantut-Wittmann, D.E.; Fernandes, A. 2016: Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(1): 22-29
Modesto, W.; Bahamondes, M.V.; Bahamondes, L. 2015: Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate Journal of Women's Health 24(8): 636-640
Lech, M.M. 2003: Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland Wiadomosci Lekarskie 56(7-8): 362-368
Lech, M.M. 2003: Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland Wiadomosci Lekarskie 56(7-8): 362-368
Lech, M.M. 2003: Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland Wiadomosci Lekarskie 56(7-8): 362-368
Stout, A.; Wood, S.; Barigye, G.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries Global Health Science and Practice 6(1): 55-72
Stout, A.; Wood, S.; Barigye, G.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries Global Health Science and Practice 6(1): 55-72
Stout, A.; Wood, S.; Barigye, G.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries Global Health Science and Practice 6(1): 55-72
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405
Harel, Z.; Wolter, K.; Gold, M.A.; Cromer, B.; Bruner, A.; Stager, M.; Bachrach, L.; Hertweck, P.; Nelson, A.; Nelson, D.; Coupey, S.; Johnson, C.C.; Burkman, R.; Bone, H. 2010: Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study Journal of Pediatric and Adolescent Gynecology 23(4): 209-214
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Heffron, R.; Mugo, N.; Were, E.; Kiarie, J.; Bukusi, E.A.; Mujugira, A.; Frenkel, L.M.; Donnell, D.; Ronald, A.; Celum, C.; Baeten, J.M.; Celum, C.; Baeten, J.M.; Donnell, D.; Coombs, R.W.; Frenkel, L.M.; Hendrix, C.W.; Lingappa, J.; McElrath, M..Juliana.; Fife, K.; Were, E.; Tumwesigye, E.; Katabira, E.; Katabira, E.; Bukusi, E.; Cohen, C.; Wangisi, J.; Campbell, J.; Tappero, J.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Mugo, N.Rwamba.; Campbell, J.; Tappero, J.; Wangisi, J. 2014: Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception Aids 28(18): 2771-2776